Compared to normal cognitive individuals, individuals with cognitive impairment had lower plasma Aβ42/40 levels [21], higher plasma neurofilament light chain (NfL) levels [22], and lower plasma tau phosphorylated at threonine 181 (p-Tau-181) [23]. Here, MAPT is linked to Cognitive impairment.